Informação sobre produto
Nome:Imeglimin
Marca:Biosynth
Descrição:Imeglimin is a drug that acts as an antidiabetic agent by targeting energy metabolism. It has been shown to reduce the levels of blood glucose and improve insulin sensitivity in patients with type 2 diabetes. Imeglimin also reduces kidney fibrosis and improves mitochondrial membrane potential, redox potential, and ATP levels in liver cells. Imeglimin has significant interactions with other drugs that affect energy metabolism, such as metformin and phenformin. These drugs should be avoided in patients taking imeglimin to avoid toxic effects on the heart, liver, or kidneys. Imeglimin is metabolized by CYP2C19 into its active form imeglimine.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:155.2 g/mol
Fórmula:C6H13N5
Pureza:Min. 95%